BioCentury
ARTICLE | Company News

Therexsys deal

February 6, 1995 8:00 AM UTC

The Keele, U.K., company signed an agreement with the U.K.'s Medical Research Council for the exclusive commercialization rights to Locus Control Region (LCR) technology as applied to viral and non-vi...